This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
The US Medical Affairs Lead (MAL), Lung is the single point of medical accountability for assigned lung oncology pipeline assets and/or indications in the US. The role leads development and execution of Medical Plans, integrating headquarters medical strategy with field medical execution to ensure robust bidirectional insight generation, support clinical trial site selection and enrollment, and build medical and evidence foundations required for successful transition of assets for commercialization.
Job Responsibility
Accountable for development and execution of US medical strategy for lung oncology pipeline assets, ensuring alignment with asset strategy and Emerging Therapeutic Area priorities
Leads the US Medical Affairs Plan and Medical Matrix Team, adapting global strategy to US clinical practice, research infrastructure, and stakeholder needs
Represents the US medical perspective on Global Medical Teams, providing a strong US voice on unmet need, trial feasibility, and external expert expectations
Partners closely with Clinical Development to inform protocol design, eligibility criteria, endpoints, and site selection to optimize US relevance and enrollment
Drives systematic generation, synthesis, and communication of US medical insights from investigators, HCPs, and research networks
Provides strategic direction to Lung MSLs on engagement priorities, insight focus areas, and ISS/SCS concepts aligned to US medical strategy
Works with Value Evidence & Outcomes partners to identify US evidence gaps and shape local evidence generation plans
Ensures high‑quality, compliant medical engagement with external lung oncology experts and cooperative groups
Manages budget and spend for assigned lung oncology assets in accordance with governance requirements
Applies sound medical governance and is accountable for medical review, approval, and compliance oversight for assigned assets
Requirements
Advanced scientific or clinical degree such as MD, PharmD, PhD, or equivalent
Eight or more years of Oncology experience in Medical Affairs, including US launch or launch preparation experience
Three or more years of experience shaping clinical trial design to fit US Market needs
Five or more years of experience developing medical strategy and evidence generation plans, and to deliver against asset operational plans
Nice to have
Experience supporting oncology pipeline or early‑asset programs
Experience influencing clinical development strategy through medical insight
Strong understanding of US oncology practice patterns and clinical trial execution
Demonstrated ability to work effectively in a complex, matrixed environment